Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive treatment options, and track the progression of the disease or its recurrence.

Apr 18, 2025 · The Drug and Alcohol Treatment Access Report (DATAR) is a DHCS system to collect data on SUD treatment capacity and waiting lists and is considered a supplement to CalOMS Tx.

Based on clinical studies over the past years, Datar Cancer Genetics has been able to develop evidence-based testing procedures both in the field of therapy management and in cancer screening.

Feb 3, 2025 · About Datar Cancer Genetics DCG is a global leader in personalized oncology, pioneering customized treatment solutions through encyclopedic cancer analysis.

We believe that relentless research, bold initiatives, sustained commitment and an unapologetic determination to succeed against cancer will help us defeat it. We dedicate ourselves to this singular …

Apr 15, 2014 · The Drug and Alcohol Treatment Access Report (DATAR) is the Department of Health Care Services (DHCS) system to collect data on treatment capacity and waiting lists and is …

trublood®, a non-invasive diagnostic biopsy for solid organ cancers, has been developed by Datar Cancer Genetics.

Early Detection of Cancer - Personalized Therapy - Blood-Based Cancer Diagnosis - Monitor Response toTreatment / Recurrence

The goal of DATAR is to collect data on substance use disorder (SUD) treatment capacity and waiting lists. DATAR provides essential information about the capacity of California’s publicly funded SUD …

Oct 17, 2023 · Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as Strategic Advisor, reinforcing its commitment to advancing …